Envoy Medical (Envoy Medical) ROCE % : -489.73% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Envoy Medical's annualized ROCE % for the quarter that ended in Dec. 2023 was -489.73%.

Envoy Medical ROCE % Historical Data

The historical data trend for Envoy Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical ROCE % Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

ROCE %

-554.11

-1,363.51

-3,529.49

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial			-	-31,416.22	-	-322.23	-489.73

Envoy Medical ROCE % Calculation

Envoy Medical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-18.371	/	( ( (2.556 - 2.519)	+	(7.64 - 6.636) )	/ 2 )
	=	-18.371	/	( (0.037	+	1.004)	/ 2 )
	=	-18.371	/	0.5205
	=	-3,529.49 %

Envoy Medical's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-26.94	/	( ( (23.601 - 13.603)	+	(7.64 - 6.636) )	/ 2 )
	=	-26.94	/	( ( 9.998	+	1.004 )	/ 2 )
	=	-26.94	/	5.501
	=	-489.73 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Envoy Medical (NAS:COCH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Envoy Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Envoy Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.